Enza Ferrero Selected Research

Phosphotransferases (Kinase)

8/2006

In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enza Ferrero Research Topics

Disease

6	Neoplasms (Cancer) 12/2019 - 10/2003
4	Inflammation (Inflammations) 11/2017 - 10/2003
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 12/2019
2	Malignant Mesothelioma 04/2018 - 08/2014
2	Ovarian Neoplasms (Ovarian Cancer) 08/2014 - 01/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 07/2008 - 06/2008
2	Breast Neoplasms (Breast Cancer) 10/2003 - 05/2002
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Spinocerebellar ataxia 28 01/2019
1	Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 06/2015
1	Demyelinating Diseases (Demyelinating Disease) 06/2015
1	Nervous System Diseases (Neurological Disorders) 06/2015
1	Ovarian Epithelial Carcinoma 01/2014
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2014
1	Wounds and Injuries (Trauma) 03/2009
1	Leukemia 07/2008
1	Infections 07/2008
1	Disease Progression 08/2006
1	Polyneuropathies (Polyneuropathy) 04/2005
1	Paraproteinemias (Monoclonal Gammopathy) 04/2005
1	Neuroblastoma 04/2005
1	Acute Promyelocytic Leukemia 05/2002

Drug/Important Bio-Agent (IBA)

2	ADP-ribosyl CyclaseIBA 10/2021 - 08/2010
2	Extracellular Matrix ProteinsIBA 12/2019 - 01/2014
2	Biological ProductsIBA 08/2014 - 01/2014
2	NAD (NADH)IBA 01/2014 - 03/2009
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2021
1	Monoclonal AntibodiesIBA 12/2019
1	Differentiation AntigensIBA 12/2019
1	ADP-ribosyl cyclase 2IBA 12/2019
1	m-AAA proteasesIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	IntegrinsIBA 11/2017
1	Lamin Type B (Lamin B)IBA 06/2015
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 08/2014
1	NAADP (nicotinic acid adenine dinucleotide phosphate)IBA 01/2014
1	nicotinic acid adenine dinucleotideIBA 01/2014
1	Adenosine Diphosphate (ADP)IBA 01/2014
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2014
1	EnzymesIBA 01/2014
1	NADP (NADPH)IBA 01/2014
1	Phosphates (Orthophosphate)IBA 01/2014
1	Diphosphates (Pyrophosphates)IBA 01/2014
1	AntigensIBA 07/2013
1	Insulin (Novolin)FDA Link 07/2008
1	ElementsIBA 06/2008
1	Phosphotransferases (Kinase)IBA 08/2006
1	Immunoglobulin M (IgM)IBA 04/2005
1	AntibodiesIBA 04/2005
1	Estrogen ReceptorsIBA 10/2003
1	Tamoxifen FDA LinkGeneric 10/2003
1	Estrogen Receptor alphaIBA 10/2003
1	SteroidsIBA 10/2003
1	Arsenic Trioxide (Trisenox)FDA Link 05/2002

Therapy/Procedure

1	Immunotherapy 10/2021
1	Therapeutics 12/2019
1	Tissue Transplantation 03/2009
1	Aftercare (After-Treatment) 10/2003